EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Making Prodrugs Stick Around: Engineering Protease-Activated Tumor Retention

Robin Kryštůfek, Jan Konvalinka iD

ACS Central Science · 22.07.2026 · 12 (7) · 888-890

DOI: 10.1021/acscentsci.6c01098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Central Science, online erschienen am 09.07.2026. Verfasst von Robin Kryštůfek und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Organic Chemistry and Biochemistry, Academy of Science of the Czech Republic, Flemingovo n. 2, 166 10 Praha 6, Czech Republic. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kang et al. combine protease-triggered activation with membrane trapping, keeping drugs in tumors longer and boosting delivery, imaging, and therapy.

Autor:innen und Institutionen

  • Institute of Organic Chemistry and Biochemistry, Academy of Science of the Czech Republic, Flemingovo n. 2, 166 10 Praha 6, Czech Republic.

ORCID-Profile: Jan Konvalinka

Zitieren

APA

Kryštůfek, R., & Konvalinka, J. (2026). Making Prodrugs Stick Around: Engineering Protease-Activated Tumor Retention. ACS Central Science, 12(7), 888-890. https://doi.org/10.1021/acscentsci.6c01098

Vancouver

Kryštůfek R, Konvalinka J. Making Prodrugs Stick Around: Engineering Protease-Activated Tumor Retention. ACS Central Science. 2026;12(7):888-890. doi:10.1021/acscentsci.6c01098

BibTeX
@article{Krytfek2026,
  author = {Kryštůfek, Robin and Konvalinka, Jan},
  title = {Making Prodrugs Stick Around: Engineering Protease-Activated Tumor Retention},
  journal = {ACS Central Science},
  year = {2026},
  volume = {12},
  number = {7},
  pages = {888--890},
  doi = {10.1021/acscentsci.6c01098}
}
Kostenlos starten →